Grant of the Options. Subject to the provisions of this Agreement, SGI hereby grants to EOS an exclusive Option for each Research Antigen designated pursuant to Section 2.1 to obtain the Exclusive License set forth in Section 4.2.1 during the Option Period.
Appears in 3 contracts
Sources: Collaboration Agreement (Seattle Genetics Inc /Wa), Collaboration Agreement (Pharmacopeia Inc), Collaboration Agreement (Pharmacopeia Inc)